You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Novel Ultra-Flexible Hybrid Circuits for Intraocular Retinal Prostheses

    SBC: PREMITEC, INC.            Topic: N

    DESCRIPTION provided by applicant Retinal prosthetic devices currently under development are designed to bypass the non functioning portion of the visual pathway photoreceptor layer in individuals suffering from diseases including retinitis pigmentosa RP and age related macular degeneration AMD Current devices enable patients to only see object positions and read large letters and furth ...

    STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  2. Efficacy and Safety of an Aerosolized Recombinant Butyrylcholinesterase Pretreatm

    SBC: Plant Vax, Inc.            Topic: 106

    DESCRIPTION provided by applicant Organophosphorus OPs compound are potent neurotoxic chemicals that are widely used in medicine industry and agriculture most notably as insecticides The neurotoxicity which is primarily a result of AChE inhibition may take the form of cholinergic crisis and death as a consequence of acute exposure or psychiatric symptoms and may lead to delayed neuropath ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  3. Clinical Development of a Therapeutic Agent for COPD

    SBC: BIOMARCK PHARMACEUTICALS, LTD            Topic: NHLBI

    DESCRIPTION provided by applicant Hypersecretion of mucus into the respiratory airways is a major contributing factor in several lung diseases including chronic pulmonary disease COPD asthma cystic fibrosis allergic rhinitis and bronchiectasis Despite the obvious medical importance there presently are no effective therapies to control excess mucus secretion in these diseases and very ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  4. Plasmodium Falciparum Whole Sporozoite Malaria Vaccine

    SBC: SANARIA INC.            Topic: NIAID

    DESCRIPTION provided by applicant The ideal tool for eliminating Plasmodium falciparum Pf the causative agent of of all malaria deaths would be a highly effective vaccine that prevents blood stage infection and thereby prevents the disease and transmission The only immunogens demonstrated able to induce andgt sustained months protective efficacy in humans are Pf sporozoit ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  5. Improved diagnostic and monitoring assays for thyroid cancer

    SBC: SOYMEDS INC            Topic: NCI

    DESCRIPTION provided by applicant Thyroid cancer is the most common type of endocrine malignancy New thyroid cancers patients are identified daily and most patients live for decades following diagnosis Thyroglobulin TG levels in the sera or in fine needle biopsies of thyroid cancer patients are routinely quantified using various agency approved e g FDA immunoassays for diagnostic and p ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  6. TB Diagnostics at the Point of Care

    SBC: AKONNI BIOSYSTEMS INC            Topic: NIBIB

    DESCRIPTION provided by applicant Of all diseases tuberculosis TB represents one of if not the greatest health disparity between whites and minorities For every TB infected white person in the United States there are an estimated African Americans Latinos Native Americans Asians and Native Hawaiian Pacific Islanders with this disease Compounded with this dispari ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  7. Augmented Reality Head Mounted Display for Magnetic Resonance Imaging Guided Inte

    SBC: ROBIN MEDICAL INC            Topic: 102

    DESCRIPTION provided by applicant The broad long term objective is to develop a low cost easy to use system that can convert diagnostic MRI scanner into a functional neurosurgical MRI suite The specific aims of the project are Develop the display only mode of the HMD that integrates MRI realtime scans and device tracking annotation into a stereoscopic D display Feasibility of such HMD ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Low-Dose MRI-Compatible Molecular Breast Imaging Device

    SBC: WEINBERG MEDICAL PHYSICS, INC.            Topic: 102

    DESCRIPTION provided by applicant Contrast enhanced MRI has been proven to be a very sensitive modality for the early diagnosis of breast cancer in young women and or in women with radiographically dense breasts The American Cancer Society recommends that high risk women with lifetime risk greater than should receive annual breast MRI screening Depending on the practitioner and study char ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  9. DNA Repair-on-a-Chip: Spatially Encoded Microwell Arrays

    SBC: TREVIGEN, INC.            Topic: NIEHS

    DESCRIPTION provided by applicant Preserving genomic integrity is essential in order to suppress cancer neurodegeneration aging and other diseases At odds with genomic preservation is DNA damage which can drive mutations sequence rearrangements and cellular toxicity DNA damage is unavoidable as DNA damaging agents are present in our environment and in our cells To counteract the deleter ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  10. Novel Manufacturing Processes for Tissue Engineered Vascular Grafts

    SBC: HUMACYTE, INC.            Topic: NHLBI

    DESCRIPTION provided by applicant This Phase IIB SBIR application is responsive to NHLBI RFA HL andquot NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart Lung Blood and Sleep Disorders and Diseases R andquot This RFA solicits work on andquot basic applied and clinical research on all product and service development related to the ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government